Public

Bulletin 175 Launched - Hypnotics update is now available to all PrescQIPP users. Due to concerns over hypnotic dependence, hypnotic prescribing has been subject to scrutiny and review for a number of ...
Bulletin 171 - Rectal Irrigation (DROP-List) is now available to all PrescQIPP users. This bulletin reviews the use of rectal irrigation to ensure proper pathways are in place before prescribing and ...
Bulletin 167 - Medical devices (DROP-List) is now available to all PrescQIPP users. The DROP-List has always sought to support Medicines Optimisation principles, which detail that "treatments of limited ...
Bulletin 161 - Wound care - Silicone scar treatment is now available to all PrescQIPP users. This bulletin and briefing review the place in therapy for silicone sheets and gels for the treatment of scar ...
Bulletin 160 - Silk and antimicrobial garments is now available to all PrescQIPP users. These resources review the place in therapy for silk and antimicrobial garments to ensure to ensure prescribing ...
Bulletin 165 - Glycopyrronium (SPOT-List) is now available to all PrescQIPP users. This bulletin is the latest SPOT(Specials Prescribing Optimisation Tool) support bulletin and focuses on the use of ...
Bulletin 162 - Polypharmacy - Agreeing treatment goals and discontinuation criteria is now available to all PrescQIPP users. This bulletin, briefing and supporting resources support prescribers in being ...
Bulletin 158 - Prescribing in ADHD is now available to all PrescQIPP users. These resources support the appropriate prescribing and review of ADHD treatments including initiation and monitoring of treatment. ...
Bulletin 149 - Management of non-neuropathic pain in primary care is now available to all PrescQIPP users. This bulletin and associated resources support medicines optimisation in non neuropathic (non ...
Bulletin 146 - Nutrition - Infant feeds update is now available to all PrescQIPP users. The infant feeds bulletin update is now available for subscribers. The bulletin discusses management and review ...
Bulletin 143 - Care homes - Supporting self administration of medicines is now available to all PrescQIPP users. This bulletin supports the implementation self administration of medicines in the care ...
Bulletin 152  - IMPACT (polypharmacy) is now available to all PrescQIPP users. The Improving Medicines and Polypharmacy Appropriateness Clinical Tool (IMPACT) updates and replaces the Optimising ...
Bulletin 153 Launched - Polypharmacy and deprescribing - Frailty is now available to all PrescQIPP users. This bulletin focuses on frailty and end of life and the specific considertaions that would apply ...
Bulletin 151 - Care homes - How to use multidisciplinary teams effectively is now available to all PrescQIPP users. These resources support the effective working and communication between members of ...
SPOT-List is now available to all PrescQIPP users. The Specials Prescribing Optimisation Tool (SPOT) is based on the national specials prescribing data. This list includes specials that appear regularly ...
Management of type 2 diabetes is now available to all PrescQIPP users. This bulletin is an update to the oral hypoglycaemics and other antidiabetic drugs bulletin. It discusses the evidence base for ...
Commissioning: Medicines in service redesign, a how to guide is now available to all PrescQIPP users. This bulletin combines the service redesign and off prescription models workplan items into one bulletin. ...
Wound care - Support bandages and stockinettes is now available to all PrescQIPP users. This bulletin reviews the place in therapy of support bandages and stockinette and is aimed at ensuring these products ...
Buccal midazolam (SPOT-List) is now available to all PrescQIPP users. This bulletin reviews the place in therapy of unlicensed buccal midazolam and switching to a licences product where appropriate. ...
Anticholinergic drugs is now available to all PrescQIPP users. This bulletin discusses appropriate treatment with anticholinergic drugs. An increasing number of systematic reviews and meta-analyses report ...